SEER Inquiry System - Home
Welcome to the SEER Inquiry System (SINQ). SINQ is a collection of questions that cancer registrars have had while coding cancer cases. Click Search to look for specific questions or to select questions for a Report.
|
|||||||
|---|---|---|---|---|---|---|---|
| Add to Report | ID | Question | Status | Last Updated | |||
| 20120085 | MP/H Rules/Histology--Ovary: Do the instructions for teratoma of the testis apply to teratoma of the ovary? See discussion. | Final | Nov 26 2012 | ||||
| 20120084 | MP/H Rules/Histology--Liver: Is this 2 primaries and, if so, what are the histology codes? See discussion. | Final | Nov 26 2012 | ||||
| 20120083 | Multiple primaries--Heme & Lymphoid Neoplasms: Is the following scenario one primary or two? See discussion. | Final | Dec 14 2012 | ||||
| 20120082 | MP/H Rules/Multiple primaries--Breast: Please tell me if this is one or two breast primaries. See discussion. | Final | Nov 18 2012 | ||||
| 20120081 | Reportability: Is VIN II-III reportable? | Final | Oct 22 2012 | ||||
| 20120080 | MP/H Rules/Multiple primaries--Kidney, renal pelvis, bladder, ureter: How many primaries should be abstracted for the following scenario? See discussion. | Final | Oct 22 2012 | ||||
| 20120078 | Reportability--Melanoma: Upon review of SINQ 20020019 and 20041034 the terms "early" or "evolving" in situ melanoma are not reportable. Does the addition of a "Clarks Level I " change reportability? See discussion. | Final | Dec 18 2012 | ||||
| 20120077 | Primary site/Histology--Heme & Lymphoid Neoplasms: Please advise regarding a situation with inconsistency between the EDITS based on the SEER Site/Type Table and the Heme/Lymph Rules and DB. See discussion. | Final | Sep 21 2012 | ||||
| 20120076 | Histology--Heme & Lymphoid Neoplasms: What histology code should I use? See discussion. | Final | Sep 21 2012 | ||||
| 20120075 | Primary site--Heme & Lymphoid Neoplasms: How should primary site be coded when a bone marrow biopsy is not done? See discussion. | Final | Sep 21 2012 | ||||
|
|||||||
